Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Efficacy and safety of resolving hard lump for non-small cell lung cancer: A Meta-analysis
Hits 1525  Download times 1242  Received:August 30, 2018  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2019.01.12
Key Words   resolving hard lump;non-small cell lung cancer;Meta-analysis;rystematic review;randomized controlled trial
Author NameAffiliationE-mail
ZHANG Lishuang Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
YANG Fengwen Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
LI Xuemei Baokang Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China lxmtcm@126.com 
ZHANG Junhua Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
JIN Xinyao Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
ZHANG Mingyan Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
FENG Rui Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
ZHAO Hongjie Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
JI Zhaochen Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China  
Abstract
    [Objective] This systematic review aims to systematically evaluate the efficacy and safety of resolving hard lump on the treatment of non-small cell lung cancer (NSCLC).[Methods] We searched CNKI datebases, WanFang, SinoMed, PubMed, Embase, The Cochrane Library from the inception to October 16th 2017, to collect randomized controlled trials (RCTs) of the resolving hard lump in treating NSCLC. Two reviewers independently screened literature, extracted date and assessed the methodological quality of included studies. Then, statistical analysis was performed by using Stata12.0 and WinBUGS1.4.3 sofware.[Resluts] A total of 40 RCTs nvolved 3201 patients were finally included,in which 5 different dosage forms and 34 interventions. There mainly were decoction, pill, capsule, mixture, and injection. The result of direct Meta-analysis showed that compared with the simple chemotherapy group, resolving hard lump prescription combined with chemotherapeutic drugs could significantly improve the clinical efficacy, improve the quality of life of patients, prolong progression free survival and decrease adverse reactions of chemotherapeutic drugs.[Conclusion] Resolving hard lump prescription combined with chemotherapeutics were more effective than the simple chemotherapy group in terms of clinical efficacy, the quality of life, and decrease adverse reactions. Due to the low quality of included studies,more high quality RCTs are needed to verify the above conclusion.

You are the 2317255 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.